UPDATED: Free webinar Saturday on what's new with prostate biopsies, featuring uropath guru Dr. Jonathan Epstein
Story is so hot. I couldn't hold it. But I forgot the registration. Sorry.
By Howard Wolinsky
I goofed. My story on the Epstein webinar got away before I was done. I apologize.
Let me give you the basics upfront.
The program will be on from noon to 1:30 p.m. Eastern on Saturday, May 17. Register for the meeting: https://us02web.zoom.us/meeting/register/JwtdomJnT3mJttTI8urvuQ
Please send questions in advance to: Howard.wolinsky@gmail.com.
Now the previous story
By Howard Wolinsky
Epstein called. I listened. Of course,
Actually, he sent me an email. And I wrote back.
Dr. Jonathan Epstein, world-renowned uropathology expert, who recently launched his new practice in the Big Apple, reminded me that he gave a moderated lecture to a prostate cancer support group. (I was the moderator.)
He spoke back in 2023 about “what patients need to know on their biopsy (and could expand if desired as to what they need to know if they have had RT or RP), where patients were able to ask me questions at the end of the session. Since then, new information is available and would be helpful for patients. I would love to do a similar session if that is something that is of interest.
Signed Jonathan
Of course I was interested, and I think you will be, too.
So The Active Surveillor is holding a free webinar, “What you need to know about your prostate biopsy--the new news,” this Saturday, May 17, from noon-1:30 p.m. Eastern. Co-sponsors are Active Surveillance Patients International and AnCan.
Register for the meeting: https://us02web.zoom.us/meeting/register/JwtdomJnT3mJttTI8urvuQ
Sign up even if you can’t make it because you’ll be notified when the video is available.
Patients who have had radiation therapy or radical prostatectomy are welcome as well.
Dr. Epstein recently launched Advanced Uropathology of New York: Global Consultation Services in New York City after nearly 40 years on the faculty at Johns Hopkins University School of Medicine. Advanced Uropathology is affiliated with Integrated Medical Professionals, PLLC, (IMP) (https://www.imppllc.com/about-imp-2/), a subsidiary of Solaris Health.
You can reach Dr. Epstein at https://advanceduropathology.com/consultation/ or directly through his email: jonathaniraepstein@gmail.com
More than 250 of you have registered. But we have room for more. Time is running out.
The Active Surveillor is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
More meetings, including a new one in the Windy City only for AS patients
—Chicago Area Active Surveillors meet in person 11:30. a.m.-1 p.m. Wednesday, May 21,
Be there or be square. But you gotta’ be there in person.
The newly formed Chicago Area Active Surveillors is meeting at
Seasons 52 in the Napa Room
3 Oakbrook Center
Oak Brook, IL 6052
If you want to join us, let me know at howard.wolinsky@gmail.com, and I’ll share details.
We have drawn members from as far away as Columbia, Missouri, for the meeting of what we believe is the largest in-person AS-only support group on the planet—certainly in the Chicago area. Maybe in the multi-verse.
—ZERO’s town hall meeting on ZOOM. Prostate cancer research—along with research on other diseases—has taken a body blow.
Attend a ZERO Prostate Cancer town hall at 7 p.m. Eastern Tuesday May 20 by ZERO to discuss the status of funding cuts under the proposed federal budget and what can be done about it. Register for the session here. More background on the cuts proposed for CDC here.
—UMiami’s Sanoj Punnen takes on the debate over transperineal vs. transrectal biopsies. Active Surveillance Patients International (ASPI)’s monthly webinar will focus on these issues in a program entitled, “The great biopsy debate: Where do we stand on transperineal vs. transrectal?”
The program will be on Saturday, May 24 from noon to 1:30 pm Eastern.
Register here:
https://zoom.us/meeting/register/UZVDHmq9Rlyw6y_mqmK0hg#/registration
Check out Punnen’s presentation of the MAST AS study at the recent meeting of the American Urological Association: https://news.med.miami.edu/improving-prostate-cancer-prediction-during-active-surveillance/
Please send questions in advance to: contactus@aspatients.org
The Active Surveillor is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid